Preoperative Breast Cancer Treatment May Be Improved By Combining 2 Anti-HER2 Drugs

[News]

Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent...

More... (http://www.medicalnewstoday.com/releases/240376.php)